Kidney medications do not differ from placebo: clinical trials have proven to be ineffective

Kidney medications do not differ from placebo

Clinical trials have been conducted at the University of Pharmacy in New South Wales, they have shown that commonly prescribed drugs for kidney treatment are no different from placebo and have no effect. For example, allopurinol, which is often prescribed to 20% of patients with kidney disease, does not improve their well-being.

To draw such conclusions, the scientists examined over 350 patients with chronic kidney disease with a risk of further progression. Allopurinol is a well-known drug prescribed to lower blood urate levels. But its clinical trials showed that the medicine acts like a placebo.

Sunil Badwe, who is one of the researchers and a senior fellow at the George Global Health Institute, believes that the findings made by him and his colleagues are important for health. One out of five patients with kidney disease takes medication to lower elevated blood urate levels.

There was no progress in treatment, and it suggests that many drugs do not bring any benefit. In addition, the popular allopurinol has side effects. It causes severe allergic reactions and skin rashes. The scientists have explored other options for treating kidney diseases that are traditionally prescribed by doctors.

They concluded that most of them are only partially effective. According to the scientists, nowadays there is an acute problem of finding new methods of treating kidney diseases.

Almost 80% of patients have elevated levels of urate in the blood and they need full treatment that they cannot receive. Most often, the disease progresses, despite the prescribed drugs being taken, which in fact do not have any effectiveness.

Drugs that have been prescribed by doctors for decades, not only do not have effectiveness, but also can harm the human health.